Displaying Clinical Allogeneic Persistence to Increase Accessibility
Time: 2:15 pm
day: Day 1 - Track B - Mid
Details:
- Preventing immune-rejection to maintain a durable off-the-shelf therapy response
- Cloaking therapies to mediate host immune evasion
- Optimising donor screening to select a high quality starting material
